Skip to main content
KEQU logo

Kewaunee Scientific Corporation

KEQUNASDAQConsumer DiscretionaryFurnishings, Fixtures & Appliances

$32.79Today:- (-)1Y −27.77%

As of Oct 23, 2026 close

Market cap
$95.78M
P/E (TTM)
11.64
Forward P/E
17.48
Dividend yield
-
52-week range
$32.00$46.57
Volume (live)
-
Avg. volume (3M)
4.12K

Kewaunee Scientific (KEQU) Cash Flow Statement

In fiscal 2026 (fiscal year ended Apr 30, 2026), Kewaunee Scientific generated $18.63M of operating cash flow and spent $3.94M on capital expenditures. That left free cash flow of $14.70M, up 16.5% from $12.62M a year earlier, or 5.2% of revenue. It repurchased $671.00K of its own shares.

Kewaunee Scientific Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Kewaunee Scientific Corporation (KEQU) - Annual data in millions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingApr 2026Apr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017
Operating Activities
Net Income0.0011.5819.061.36-6.00-3.61-4.621.695.374.62
Depreciation & Amortization6.284.763.132.872.772.692.652.572.762.70
Deferred Income Tax-0.02-2.20-7.130.520.121.661.900.201.130.23
Stock Based Compensation2.131.441.030.890.730.630.250.200.360.20
Change in Working Capital-0.19-2.023.21-9.54-5.59-0.523.62-2.23-6.773.87
Change in Accounts Receivable3.30-6.740.74-4.95-8.46-6.094.83-0.66-3.12-2.09
Change in Inventory2.323.351.211.91-7.28-1.191.880.46-2.730.69
Change in Accounts Payable-5.150.580.69-5.5611.896.33-2.02-0.064.560.69
Change in Other Working Capital-0.371.150.29-1.51-3.100.43-1.07-1.97-5.494.58
Other Operating Activities-0.371.15-6.850.640.210.050.360.070.340.04
Net Cash from Operating Activities18.6314.7819.56-3.79-7.890.914.162.493.1811.66
Investing Activities
Capital Expenditures-3.94-2.17-4.37-4.15-1.91-2.40-2.47-4.21-3.40-2.61
Acquisitions0.00-28.740.000.000.000.000.000.000.000.00
Other Investing Activities0.000.000.000.000.000.000.000.000.190.13
Net Cash from Investing Activities-3.94-30.90-4.37-4.15-1.91-2.40-2.47-4.21-3.20-2.48
Financing Activities
Debt Repayment-44.93-77.72-0.73-58.72-64.602.09-6.084.45-0.62-0.65
Common Stock Issued0.000.000.000.000.000.000.00-0.040.010.19
Common Stock Repurchased-0.67-1.60-2.000.000.000.000.000.040.000.00
Dividends Paid0.000.000.000.000.000.00-1.04-2.03-1.79-1.57
Other Financing Activities-1.01-1.76-0.49-0.580.00-0.11-0.34-0.09-0.070.13
Net Cash from Financing Activities-19.337.41-3.0114.9311.031.98-7.462.33-2.48-2.08
Summary
Effect of Forex Changes on Cash-0.92-0.07-0.05-0.07-0.080.02-0.18-0.41-0.290.19
Net Change in Cash-5.55-8.7712.126.921.160.52-5.940.20-2.797.28
Cash at Beginning of Period17.1625.9413.826.895.735.2211.1610.9612.515.22
Cash at End of Period11.6217.1625.9413.826.895.735.2211.169.7212.51
Free Cash Flow14.7012.6215.19-7.94-9.79-1.491.70-1.72-0.219.05
Supplemental Disclosures
Interest Paid-3.371.801.860.480.07----
Income Taxes Paid-3.976.243.161.01-1.80----

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Kewaunee Scientific Cash Flow

What is Kewaunee Scientific's free cash flow?

Kewaunee Scientific generated free cash flow of $14.70M in fiscal 2026 (fiscal year ended Apr 30, 2026), operating cash flow of $18.63M minus $3.94M of capital expenditures. That was up 16.5% from $12.62M a year earlier. Free cash flow equaled 5.2% of revenue.

How much does Kewaunee Scientific spend on capital expenditures?

Kewaunee Scientific spent $3.94M on capital expenditures in fiscal 2026, compared with $2.17M a year earlier. That equals 21.1% of operating cash flow.

Does Kewaunee Scientific pay dividends or buy back shares?

Yes. In fiscal 2026 Kewaunee Scientific returned $671.00K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition